Energy News / Shareholders Foundation, Inc.

NASDAQ:PTIE Investor Alert: Investigation over Potential Wrongdoing at Pain Therapeutics, Inc

Via: ReleaseWire

Updated 12:15 PM CDT, Wed, March 28,2018

An investigation on behalf of investors in Pain Therapeutics, Inc. (NASDAQ: PTIE) shares over potential wrongdoing at Pain Therapeutics, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 03/28/2018 -- An investigation was announced for investors in shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) was announced concerning possible breaches of fiduciary duties by certain officers and directors.

Investors in Pain Therapeutics, Inc. (NASDAQ: PTIE) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Pain Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Austin, TX based Pain Therapeutics, Inc. develops drugs for nervous system disorders in the United States. Shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) declined from $21.00 per share on September 19, 2016 to as low as $3.15 per share in August 2017.

On March 27, 2018, NASDAQ: PTIE shares closed at $6.50 per share.

Those who purchased shares of Pain Therapeutics, Inc. (NASDAQ: PTIE), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqptie-investor-alert-investigation-over-potential-wrongdoing-at-pain-therapeutics-inc-956029.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com